These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3021300)

  • 1. Onset of pancuronium and d-tubocurarine blockade with priming.
    Donati F; Lahoud J; Walsh CM; Lavelle PA; Bevan DR
    Can Anaesth Soc J; 1986 Sep; 33(5):571-7. PubMed ID: 3021300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated onset and delayed recovery of d-tubocurarine blockade with pancuronium in infants and children.
    Smith CE; Baxter M; Bevan JC; Donati F; Bevan DR
    Can J Anaesth; 1987 Nov; 34(6):555-9. PubMed ID: 3677278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synergistic effect of two different nondepolarizing muscle relaxants on intraocular pressure.
    Abdulla WY
    J Clin Anesth; 1993; 5(1):5-11. PubMed ID: 8442968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
    Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular effects of enflurane, alone and combined with d-Tubocurarine, pancuronium, and succinylcholine, in man.
    Fogdall RP; Miller RD
    Anesthesiology; 1975 Feb; 42(2):173-8. PubMed ID: 1115366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of d-tubocurarine pretreatment on succinylcholine twitch augmentation and neuromuscular blockade.
    Szalados JE; Donati F; Bevan DR
    Anesth Analg; 1990 Jul; 71(1):55-9. PubMed ID: 2363529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridostigmine as an antagonist of d-tubocurarine-induced and pancuronium-induced neuromuscular blockade.
    Ravin MB
    Anesth Analg; 1975; 54(3):317-21. PubMed ID: 1169015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fade characteristics and onset times following administration of pancuronium, tubocurarine and a mixture of both agents.
    Cashman JN; Jones RM; Vella LM
    Br J Anaesth; 1985 May; 57(5):488-92. PubMed ID: 3994882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of atracurium by pancuronium and d-tubocurarine.
    Gerber HR; Romppainen J; Schwinn W
    Can Anaesth Soc J; 1986 Sep; 33(5):563-70. PubMed ID: 3533236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing enflurane concentrations and d-tubocurarine neuromuscular blockade.
    Gencarelli PJ; Miller RD; Eger EI; Newfield P
    Anesthesiology; 1982 Mar; 56(3):192-4. PubMed ID: 7059028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium carbonate and neuromuscular blocking agents.
    Hill GE; Wong KC; Hodges MR
    Anesthesiology; 1977 Feb; 46(2):122-6. PubMed ID: 835845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of d-tubocurarine-induced neuromuscular blockade with a mixture of 4-aminopyridine and neostigmine in man.
    Wirtavuori K; Salmenperä M; Tammisto T
    Can Anaesth Soc J; 1984 Nov; 31(6):624-30. PubMed ID: 6093961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sufentanil: the effect on cardiocirculatory parameters and intubation conditions on administration of pancuronium or vecuronium].
    Janik R; Dick W
    Anaesthesist; 1989 Dec; 38(12):673-80. PubMed ID: 2575875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade.
    Donati F; Lahoud J; McCready D; Bevan DR
    Can J Anaesth; 1987 Nov; 34(6):589-93. PubMed ID: 3677283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency?
    Kopman AF
    Anesthesiology; 1989 Jun; 70(6):915-20. PubMed ID: 2729631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Priming" with neostigmine: failure to accelerate reversal of single twitch and train-of-four responses.
    Donati F; Smith CE; Wiesel S; Bevan DR
    Can J Anaesth; 1989 Jan; 36(1):30-4. PubMed ID: 2644051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tetanus-Myomechanographic measurement of receptor liberation by pyridostigmine in neuromuscular block produced by d-tubocurarine, gallamine, pancuronium or alcuronium (author's transl)].
    Barth L; Dannhorn R
    Prakt Anaesth; 1979 Aug; 14(4):303-12. PubMed ID: 493225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative evaluation of intubating doses of atracurium, d-tubocurarine, pancuronium and vecuronium in children.
    Montgomery CJ; Steward DJ
    Can J Anaesth; 1988 Jan; 35(1):36-40. PubMed ID: 2894902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone.
    Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH; deBros FM
    Anesth Analg; 1981 Jan; 60(1):12-7. PubMed ID: 7192943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine.
    Donati F; McCarroll SM; Antzaka C; McCready D; Bevan DR
    Anesthesiology; 1987 Apr; 66(4):471-6. PubMed ID: 3565812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.